J. Christiansen

发表

Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial.

John M S Bartlett, Hein Putter, Cornelis J H van de Velde, 2016, Archives of pathology & laboratory medicine.

Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature.

Gopalakrishnapillai Anilkumar, Donald B Kohn, A. Rajasekaran, 2006, Microvascular research.

N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy

N. Bander, A. Rajasekaran, J. Christiansen, 2005, Molecular Cancer Therapeutics.

Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE–mediated apical targeting of prostate-specific membrane antigen

N. Bander, T. Weimbs, A. Rajasekaran, 2006, Molecular Cancer Therapeutics.

Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line

N. Bander, L. Goodglick, A. Rajasekaran, 2003, The Prostate.

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis.

A. Rajasekaran, J. Christiansen, 2006, Cancer research.

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

W. Curran, Meihua Wang, D. Brachman, 2013, International journal of radiation oncology, biology, physics.

Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix.

A. Rajasekaran, S. Barwe, D. Kohn, 2007, International journal of oncology.

Distinct contributions of microtubule subtypes to cell membrane shape and stability.

J. Gimzewski, M. Teitell, R. Shen, 2007, Nanomedicine : nanotechnology, biology, and medicine.

TRKA expression and NTRK1 gene copy number across solid tumours

E. Valtorta, S. Veronese, A. Sartore-Bianchi, 2018, Journal of Clinical Pathology.

Biological impediments to monoclonal antibody-based cancer immunotherapy.

A. Rajasekaran, J. Christiansen, 2004, Molecular cancer therapeutics.

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

David J. Harrison, Mark Gustavson, D. Harrison, 2011, Journal of visualized experiments : JoVE.

Is prostate-specific membrane antigen a multifunctional protein?

A. Rajasekaran, J. Christiansen, G. Anilkumar, 2005, American journal of physiology. Cell physiology.

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Adrian V. Lee, S. McDonald, D. Rimm, 2010, Clinical Cancer Research.

Validation of IHC4 algorithms for prediction of risk of recurrence in early breast cancer using both conventional and quantitative IHC approaches

H. Putter, D. Rea, D. Rimm, 2012 .

Prerequisite for Carcinoma Invasion and Metastasis Reassessing Epithelial to Mesenchymal Transition as a

A. Rajasekaran, J. Christiansen, 2006 .

Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability

N. Rao, K. Sakamoto, A. Rajasekaran, 2008, Molecular Cancer Therapeutics.

Automated analysis of tissue microarrays.

D. Rimm, M. Dolled-Filhart, R. Camp, 2010, Methods in molecular biology.

Can Mol Sub Fac

Adrian V. Lee, S. McDonald, D. Rimm, 2010 .